Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
43.83
+0.14 (0.32%)
Nov 21, 2024, 1:39 PM EST - Market open
Mirum Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 307.03 | 186.37 | 77.06 | 19.14 | - | - | Upgrade
|
| Revenue Growth (YoY) | 112.14% | 141.85% | 302.66% | - | - | - | Upgrade
|
| Cost of Revenue | 83.88 | 47.04 | 12.37 | 1.9 | - | - | Upgrade
|
| Gross Profit | 223.15 | 139.34 | 64.69 | 17.24 | - | - | Upgrade
|
| Selling, General & Admin | 191.58 | 145.88 | 89.07 | 59.22 | 22.69 | 11.75 | Upgrade
|
| Research & Development | 127.54 | 102.61 | 106.84 | 131.43 | 81.61 | 42.99 | Upgrade
|
| Operating Expenses | 319.11 | 248.49 | 195.91 | 190.65 | 104.3 | 54.74 | Upgrade
|
| Operating Income | -95.97 | -109.15 | -131.22 | -173.41 | -104.3 | -54.74 | Upgrade
|
| Interest Expense | -14.3 | -15.11 | -15.98 | -17.59 | -0.34 | - | Upgrade
|
| Interest & Investment Income | 14.36 | 13.74 | 3.86 | 0.37 | 1.56 | 2.23 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.98 | -51.9 | 1.27 | 106.69 | -0.19 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -97.98 | -162.42 | -142.07 | -83.95 | -103.26 | -52.53 | Upgrade
|
| Pretax Income | -97.98 | -162.42 | -142.07 | -83.95 | -103.26 | -52.53 | Upgrade
|
| Income Tax Expense | 1.83 | 0.99 | -6.41 | 0.04 | 0.01 | 0.02 | Upgrade
|
| Net Income | -99.81 | -163.42 | -135.67 | -83.99 | -103.27 | -52.55 | Upgrade
|
| Net Income to Common | -99.81 | -163.42 | -135.67 | -83.99 | -103.27 | -52.55 | Upgrade
|
| Shares Outstanding (Basic) | 47 | 41 | 34 | 30 | 25 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 41 | 34 | 30 | 25 | 11 | Upgrade
|
| Shares Change (YoY) | 22.57% | 20.31% | 12.07% | 20.08% | 119.84% | 1177.21% | Upgrade
|
| EPS (Basic) | -2.12 | -4.00 | -4.01 | -2.77 | -4.09 | -4.58 | Upgrade
|
| EPS (Diluted) | -2.12 | -4.00 | -4.02 | -2.77 | -4.09 | -4.58 | Upgrade
|
| Free Cash Flow | -2.2 | -71.05 | -120.41 | -132.78 | -89.3 | -39.64 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -1.74 | -3.54 | -4.38 | -3.54 | -3.45 | Upgrade
|
| Gross Margin | 72.68% | 74.76% | 83.94% | 90.06% | - | - | Upgrade
|
| Operating Margin | -31.26% | -58.57% | -170.28% | -906.12% | - | - | Upgrade
|
| Profit Margin | -32.51% | -87.68% | -176.05% | -438.85% | - | - | Upgrade
|
| Free Cash Flow Margin | -0.72% | -38.12% | -156.26% | -693.81% | - | - | Upgrade
|
| EBITDA | -72.9 | -98.33 | -127.98 | -172.82 | -103.99 | -54.6 | Upgrade
|
| EBITDA Margin | -23.74% | -52.76% | -166.08% | - | - | - | Upgrade
|
| D&A For EBITDA | 23.07 | 10.83 | 3.24 | 0.6 | 0.31 | 0.14 | Upgrade
|
| EBIT | -95.97 | -109.15 | -131.22 | -173.41 | -104.3 | -54.74 | Upgrade
|
| EBIT Margin | -31.26% | -58.57% | -170.28% | - | - | - | Upgrade
|
| Revenue as Reported | 307.03 | 186.37 | 77.06 | 19.14 | - | - | Upgrade
|
| Advertising Expenses | - | 6.3 | 4 | 9.2 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.